Stock listing

OTC:SHPHF Sihuan Pharmaceutical Holdings Group Ltd. Stock

US listing (OTC) of Sihuan Pharmaceutical Holdings Group Ltd. · home listing HKEX:460

Follow Sihuan Pharmaceutical Holdings Group Ltd. into a list and get an email when it puts out news.

Share price · OTC:SHPHF

$0.12 USD 0.00 (0.0%)

Close on Oct 19, 2026

Day range
$0.12 – $0.12 USDOct 19, 2026
Market cap
$1.92B USDAt the close on Oct 19, 2026 · price × 15.98B shares outstanding
Sihuan Pharmaceutical Holdings Group Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
HKEX:460 · Home$0.715 HKD+0.010 (+1.4%)14,073,000$0.700$0.720$0.695$0.705Close on Oct 20, 2026
Frankfurt:TEL1€0.08 EUR+0.001 (+1.3%)—€0.08€0.08€0.08€0.079Close on Oct 20, 2026
OTC:SHPHF$0.12 USD0.00 (0.0%)—$0.12$0.12$0.12$0.12Close on Oct 19, 2026
Ticker
OTC:SHPHF
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Latest news

Voluntary announcement- phase iii clinical study data of xuanzhu biopharm's anaprazole sodium for reflux esophagitis presented at ueg week 2026

Oct 21, 2026

Voluntary announcement - polycaprolactone microsphere facial filler for injection and hyaluronic acid sodium composite solution for injection independently developed by meiyan space, a subsidiary of Sihuan Pharmaceutical, approved for market launch in hong kong

Oct 20, 2026

Voluntary announcement-Sihuan Pharmaceutical completed a strategic investment in canton biologics to enhance the layout of the entire industrial chain of regenerative medical aesthetics

Oct 8, 2026

Voluntary announcement - new specifications of skin booster (brand name: dongyan) of Sihuan Pharmaceutical approved for launch by nmpa

Oct 5, 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

Oct 2, 2026

Notification Letter and Request Form to Non-registered Holder

Sep 16, 2026

Notification Letter and Change Request Form to Registered Shareholder

Sep 16, 2026

Interim Report 2026

Sep 16, 2026

Voluntary announcement - insulin aspart 30 injection developed by Sihuan Pharmaceutical achieved equivalent clinical results in efficacy and safety study as originator drug

Jul 30, 2021

Voluntary announcement-entering into strategic cooperation agreement between jilin huisheng biopharmaceutical and porton pharma

Apr 28, 2021

All Sihuan Pharmaceutical Holdings Group Ltd. news

Decks

Sihuan Pharmaceutical Holdings Group Ltd. on 6ix

News releases
8 in the last 12 months · 23 in all · newest Oct 21, 2026 · oldest 2019
Decks
8 decks · latest March 2025

Where Sihuan Pharmaceutical Holdings Group Ltd. is listed

ListingExchangeCountryCurrency
HKEX:460 四環醫藥 · Home listingHKEXHong KongHKD
Lang & Schwarz:A1C72GLang & SchwarzGermanyEUR
LS Exchange:A1C72GLS ExchangeGermanyEUR
Frankfurt:TEL1FrankfurtGermanyEUR
OTC:SHPHF · This pageOTCUnited StatesUSD
Munich:TEL1MunichGermanyEUR
Stuttgart:TEL1StuttgartGermanyEUR
Tradegate:TEL1TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Sihuan Pharmaceutical Holdings Group Ltd.